| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $233.8M | +16.1% |
| R&D Expense | $67.7M | +15.0% |
| SG&A Expense | $80.9M | +6.6% |
| Operating Income | -$8.7M | +39.0% |
| Pre-tax Income | -$15.3M | +26.4% |
| Income Tax | $354K | +72.7% |
| Net Income | -$15.6M | +25.3% |
| EPS (Basic) | -$0.08 | +27.3% |
| EPS (Diluted) | -$0.08 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.0M | -1.5% |
| Accounts Receivable | $30.4M | +2.0% |
| Inventory | $56.1M | +47.1% |
| Current Assets | $174.4M | +14.7% |
| Total Assets | $221.9M | +10.4% |
| Current Liabilities | $100.8M | +58.5% |
| Total Liabilities | $156.9M | +8.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.8M | -57.4% |
| Capital Expenditures | $3.7M | +31.4% |
| Investing Cash Flow | -$6.2M | +24.2% |
| Financing Cash Flow | $231K | -95.3% |
| Free Cash Flow | $1.1M | -87.0% |
| +27.3% |
| Stockholders' Equity |
| $64.2M |
| +14.4% |